Table 3. Interaction of hyperbaric pressure and the use of pharmacologic agents in animal studies; ATA − atmospheres absolute pressure; 1 ATA − control group had drug but remained at 1 ATA; * denotes an additional control group without drug but at test pressure; DCS − decompression sickness; EC − Escherichia coli; He − helium; HPNS − high-pressure nervous syndrome; LoE − level of evidence; MIC − minimum inhibitory concentration; MK-801 − dizocilpine; n − number; N2 − nitrogen; NA − not applicable; NR − not reported; PC − pressure chamber; PCP − phencyclidine; SA − Staphylococcus aureus; Salm − Salmonella sp; SKF − alazocine; U − unknown .
| Reference | n | Type | Drug | Control (ATA) | Pressure (ATA) | Bottom time (h) | Location | Blinded | Outcome | Results | LoE |
| 29 | 138 | Rats | Salicylate | 1* | 9 | 3.5 | PC | Yes | Anti-pyretic effect | No interaction | Ib |
| 28 | U | SA, EC | Antibiotics | 1 | Multiple | 16 | OW | N/A | Antibiotic efficacy | Increased MIC: penicillin for SA | IIb |
| 24 | 40 | Rats | Lithium | 1* | 19.2 | NR | PC | Yes | N2 narcosis HPNS | Reduced narcosis; potentiation of HPNS | Ib |
| 22 | 78 | Rats | Diazepam | 1 | 90 | 2.5 | PC | NR | Anesthetic and anticonvulsive effect; HPNS | Prevention of convulsion; reduction of HPNS | IIb |
| 30 | U | Dogs | Theophylline | 1 | 6 | U | PC | No | Pharmacokinetics | No changes | IIb |
| 31 | U | Dogs | Meperidine | 1 | 6 | U | PC | No | Pharmacokinetics | No changes | IIb |
| 33 | U | Dogs | Pentobarbital | 1 | 6 | U | PC | No | Pharmacokinetics | No changes | IIb |
| 32 | U | Dogs | Salicylate | 1 | 6 | U | PC | No | Pharmacokinetics | Increased clearance at 2.8 ATA and 100% O2 | IIb |
| 23 | 8 | Baboons | Sodium valproate | * only | 61 | 5 | PC | Yes | Effect on HPNS | Reduced severity | Ib |
| 34 | 25 | Rats | NMDA antagonists | 1* | till onset HPNS | several | PC | NR | Effect on HPNS | Little or no effect | Ib |
| 27 | U | SA, EC, Salm | Antibiotics | 1 | 36; 71 | 18 | PC | N/A | Antibiotic efficacy | Increased MIC: penicillin for SA; gentamycin and rifampicin for EC + Salm | IIb |
| 25 | 19 | Rats | Losartan | 1* | 5 | 30 min x 40 d | PC | NR | Cardiac function | Prevention of change | Ib |
| 26 | 67 | Mice | Sildenafil | * only | 10.2 | 45 min | PC | Yes | DCS | Increased incidence | Ib |